Skip to main content
Top
Published in: Journal of Interventional Cardiac Electrophysiology 2/2019

01-11-2019

Public reporting on cardiac electrophysiology procedures and outcomes: where are we now and where are we headed?

Authors: Samuel M. Kim, Jim W. Cheung

Published in: Journal of Interventional Cardiac Electrophysiology | Issue 2/2019

Login to get access

Abstract

Over the years, public reporting of patient outcomes has been promoted as a means to improve healthcare quality. More recently, in response to dramatic rises in healthcare costs, the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 was implemented in an effort to link quality with reimbursement. As part of a value-based model, public reporting of procedural outcomes has been incorporated into this initiative. Outcomes measures that have been introduced in cardiology include heart failure readmission and post-myocardial infarction medication prescription. Public reporting of these data has led not only to positive changes but also to unintended negative consequences. The limited number of existing registries and lack of clear consensus on quality metrics have posed challenges for quality and value assessment in cardiac electrophysiology. After learning from the lessons of existing models of public reporting, physicians, professional societies, stakeholders, and patients will need to collaborate to develop a health care model that can improve outcomes and reduce waste.
Literature
1.
go back to reference Topol EJ, Califf RM. Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med. 1994;120(1):65–70.CrossRef Topol EJ, Califf RM. Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med. 1994;120(1):65–70.CrossRef
2.
go back to reference Potter BJ, Yeh RW, Pinto DS. Public reporting of PCI outcomes: for better or for worse. Curr Cardiol Rep. 2014;16(7):500.CrossRef Potter BJ, Yeh RW, Pinto DS. Public reporting of PCI outcomes: for better or for worse. Curr Cardiol Rep. 2014;16(7):500.CrossRef
3.
go back to reference Hartman M, Martin AB, Espinosa N, Catlin A, The National Health Expenditure Accounts Team. National health care spending in 2016: spending and enrollment growth slow after initial coverage expansions. Health Aff (Millwood). 2018;37(1):150–60.CrossRef Hartman M, Martin AB, Espinosa N, Catlin A, The National Health Expenditure Accounts Team. National health care spending in 2016: spending and enrollment growth slow after initial coverage expansions. Health Aff (Millwood). 2018;37(1):150–60.CrossRef
4.
go back to reference Hussey PS, Liu JL, White C. The Medicare access and CHIP reauthorization act: effects on Medicare payment policy and spending. Health Aff (Millwood). 2017;36(4):697–705.CrossRef Hussey PS, Liu JL, White C. The Medicare access and CHIP reauthorization act: effects on Medicare payment policy and spending. Health Aff (Millwood). 2017;36(4):697–705.CrossRef
5.
go back to reference Findlay S. Health policy brief: implementing MACRA. Health Aff (Millwood) 2017. Findlay S. Health policy brief: implementing MACRA. Health Aff (Millwood) 2017.
6.
go back to reference Casalino LP. The Medicare access and CHIP reauthorization act and the corporate transformation of American medicine. Health Aff (Millwood). 2017;36(5):865–9.CrossRef Casalino LP. The Medicare access and CHIP reauthorization act and the corporate transformation of American medicine. Health Aff (Millwood). 2017;36(5):865–9.CrossRef
8.
go back to reference Wasfy JH, Borden WB, Secemsky EA, McCabe JM, Yeh RW. Public reporting in cardiovascular medicine: accountability, unintended consequences, and promise for improvement. Circulation. 2015;131(17):1518–27.CrossRef Wasfy JH, Borden WB, Secemsky EA, McCabe JM, Yeh RW. Public reporting in cardiovascular medicine: accountability, unintended consequences, and promise for improvement. Circulation. 2015;131(17):1518–27.CrossRef
9.
go back to reference Ray JC, Kusumoto F. The transition to value-based care. J Interv Card Electrophysiol. 2016;47(1):61–8.CrossRef Ray JC, Kusumoto F. The transition to value-based care. J Interv Card Electrophysiol. 2016;47(1):61–8.CrossRef
10.
go back to reference Anhang Price R, Elliott MN, Zaslavsky AM, Hays RD, Lehrman WG, Rybowski L, et al. Examining the role of patient experience surveys in measuring health care quality. Med Care Res Rev. 2014;71(5):522–54.CrossRef Anhang Price R, Elliott MN, Zaslavsky AM, Hays RD, Lehrman WG, Rybowski L, et al. Examining the role of patient experience surveys in measuring health care quality. Med Care Res Rev. 2014;71(5):522–54.CrossRef
11.
go back to reference Fonarow GC, Konstam MA, Yancy CW. The hospital readmission reduction program is associated with fewer readmissions, more deaths: time to reconsider. J Am Coll Cardiol. 2017;70(15):1931–4.CrossRef Fonarow GC, Konstam MA, Yancy CW. The hospital readmission reduction program is associated with fewer readmissions, more deaths: time to reconsider. J Am Coll Cardiol. 2017;70(15):1931–4.CrossRef
12.
go back to reference Lilford RJ, Brown CA, Nicholl J. Use of process measures to monitor the quality of clinical practice. BMJ. 2007;335(7621):648–50.CrossRef Lilford RJ, Brown CA, Nicholl J. Use of process measures to monitor the quality of clinical practice. BMJ. 2007;335(7621):648–50.CrossRef
13.
go back to reference Hannan EL, Cozzens K, King SB 3rd, Walford G, Shah NR. The New York state cardiac registries: history, contributions, limitations, and lessons for future efforts to assess and publicly report healthcare outcomes. J Am Coll Cardiol. 2012;59(25):2309–16.CrossRef Hannan EL, Cozzens K, King SB 3rd, Walford G, Shah NR. The New York state cardiac registries: history, contributions, limitations, and lessons for future efforts to assess and publicly report healthcare outcomes. J Am Coll Cardiol. 2012;59(25):2309–16.CrossRef
14.
go back to reference Dehmer GJ, Jennings J, Madden RA, Malenka DJ, Masoudi FA, McKay CR, et al. The national cardiovascular data registry voluntary public reporting program: an interim report from the NCDR public reporting advisory group. J Am Coll Cardiol. 2016;67(2):205–15.CrossRef Dehmer GJ, Jennings J, Madden RA, Malenka DJ, Masoudi FA, McKay CR, et al. The national cardiovascular data registry voluntary public reporting program: an interim report from the NCDR public reporting advisory group. J Am Coll Cardiol. 2016;67(2):205–15.CrossRef
15.
go back to reference Miller G, Hughes-Cromwick P, Roehrig C. National spending on cardiovascular disease, 1996-2008. J Am Coll Cardiol. 2011;58(19):2017–9.CrossRef Miller G, Hughes-Cromwick P, Roehrig C. National spending on cardiovascular disease, 1996-2008. J Am Coll Cardiol. 2011;58(19):2017–9.CrossRef
16.
go back to reference Friedman DJ, Al-Khatib SM. Measuring quality in electrophysiology. J Interv Card Electrophysiol. 2016;47(1):5–10.CrossRef Friedman DJ, Al-Khatib SM. Measuring quality in electrophysiology. J Interv Card Electrophysiol. 2016;47(1):5–10.CrossRef
17.
go back to reference Kusumoto FM, Hao SC, Slotwiner DJ, Cheung JW, Hsu JC, Kowalski M, et al. Arrhythmia care in a value-based environment: past, present, and future: developed and endorsed by the heart rhythm society (HRS). Heart Rhythm. 2018;15(2):e5–e15.CrossRef Kusumoto FM, Hao SC, Slotwiner DJ, Cheung JW, Hsu JC, Kowalski M, et al. Arrhythmia care in a value-based environment: past, present, and future: developed and endorsed by the heart rhythm society (HRS). Heart Rhythm. 2018;15(2):e5–e15.CrossRef
18.
go back to reference Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.CrossRef Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37.CrossRef
21.
go back to reference Fontenla A, Garcia-Fernandez J, Ibanez JL, Spanish Catheter Ablation Registry collaborators. Spanish catheter ablation registry. 16th official report of the Spanish society of cardiology working group on electrophysiology and arrhythmias (2016). Rev Esp Cardiol (Engl Ed). 2017;70(11):971–82.CrossRef Fontenla A, Garcia-Fernandez J, Ibanez JL, Spanish Catheter Ablation Registry collaborators. Spanish catheter ablation registry. 16th official report of the Spanish society of cardiology working group on electrophysiology and arrhythmias (2016). Rev Esp Cardiol (Engl Ed). 2017;70(11):971–82.CrossRef
22.
go back to reference Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC. Get With the Guidelines Steering Committee and Hospitals. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get with the guidelines-heart failure). Am J Cardiol. 2011;107(12):1818–23.CrossRef Krantz MJ, Ambardekar AV, Kaltenbach L, Hernandez AF, Heidenreich PA, Fonarow GC. Get With the Guidelines Steering Committee and Hospitals. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get with the guidelines-heart failure). Am J Cardiol. 2011;107(12):1818–23.CrossRef
23.
go back to reference Dehmer GJ, Drozda JP Jr, Brindis RG, Masoudi FA, Rumsfeld JS, Slattery LE, et al. Public reporting of clinical quality data: an update for cardiovascular specialists. J Am Coll Cardiol. 2014;63(13):1239–45.CrossRef Dehmer GJ, Drozda JP Jr, Brindis RG, Masoudi FA, Rumsfeld JS, Slattery LE, et al. Public reporting of clinical quality data: an update for cardiovascular specialists. J Am Coll Cardiol. 2014;63(13):1239–45.CrossRef
24.
go back to reference Campanella P, Vukovic V, Parente P, Sulejmani A, Ricciardi W, Specchia ML. The impact of public reporting on clinical outcomes: a systematic review and meta-analysis. BMC Health Serv Res. 2016;16:296.CrossRef Campanella P, Vukovic V, Parente P, Sulejmani A, Ricciardi W, Specchia ML. The impact of public reporting on clinical outcomes: a systematic review and meta-analysis. BMC Health Serv Res. 2016;16:296.CrossRef
25.
go back to reference Cox ZL, Lai P, Lewis CM, Lenihan DJ. Centers for Medicare and Medicaid services’ readmission reports inaccurately describe an institution’s decompensated heart failure admissions. Clin Cardiol. 2017;40(9):620–5.CrossRef Cox ZL, Lai P, Lewis CM, Lenihan DJ. Centers for Medicare and Medicaid services’ readmission reports inaccurately describe an institution’s decompensated heart failure admissions. Clin Cardiol. 2017;40(9):620–5.CrossRef
26.
go back to reference Gupta A, Allen LA, Bhatt DL, Cox M, DeVore AD, Heidenreich PA, et al. Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. 2018;3(1):44–53.CrossRef Gupta A, Allen LA, Bhatt DL, Cox M, DeVore AD, Heidenreich PA, et al. Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure. JAMA Cardiol. 2018;3(1):44–53.CrossRef
27.
go back to reference Green J, Wintfeld N. Report cards on cardiac surgeons. Assessing New York State’s approach. N Engl J Med. 1995;332(18):1229–32.CrossRef Green J, Wintfeld N. Report cards on cardiac surgeons. Assessing New York State’s approach. N Engl J Med. 1995;332(18):1229–32.CrossRef
28.
go back to reference Joynt KE, Blumenthal DM, Orav EJ, Resnic FS, Jha AK. Association of public reporting for percutaneous coronary intervention with utilization and outcomes among medicare beneficiaries with acute myocardial infarction. JAMA. 2012;308(14):1460–8.CrossRef Joynt KE, Blumenthal DM, Orav EJ, Resnic FS, Jha AK. Association of public reporting for percutaneous coronary intervention with utilization and outcomes among medicare beneficiaries with acute myocardial infarction. JAMA. 2012;308(14):1460–8.CrossRef
29.
go back to reference Salerno AM, Horwitz LI, Kwon JY, Herrin J, Grady JN, Lin Z, et al. Trends in readmission rates for safety net hospitals and non-safety net hospitals in the era of the US hospital readmission reduction program: a retrospective time series analysis using Medicare administrative claims data from 2008 to 2015. BMJ Open. 2017;7:e016149.CrossRef Salerno AM, Horwitz LI, Kwon JY, Herrin J, Grady JN, Lin Z, et al. Trends in readmission rates for safety net hospitals and non-safety net hospitals in the era of the US hospital readmission reduction program: a retrospective time series analysis using Medicare administrative claims data from 2008 to 2015. BMJ Open. 2017;7:e016149.CrossRef
30.
go back to reference Pokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, et al. Implantable cardioverter-defibrillator use among Medicare patients with low ejection fraction after acute myocardial infarction. JAMA. 2015;313(24):2433–40.CrossRef Pokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, et al. Implantable cardioverter-defibrillator use among Medicare patients with low ejection fraction after acute myocardial infarction. JAMA. 2015;313(24):2433–40.CrossRef
31.
go back to reference Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, et al. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med. 2012;172(8):634,41. Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, et al. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med. 2012;172(8):634,41.
32.
go back to reference Friedman DJ, Parzynski CS, Varosy PD, Prutkin JM, Patton KK, Mithani A, et al. Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1(8):900–11.CrossRef Friedman DJ, Parzynski CS, Varosy PD, Prutkin JM, Patton KK, Mithani A, et al. Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States. JAMA Cardiol. 2016;1(8):900–11.CrossRef
33.
go back to reference Xian Y, Hammill BG, Curtis LH. Data sources for heart failure comparative effectiveness research. Heart Fail Clin. 2013;9(1):1–13.CrossRef Xian Y, Hammill BG, Curtis LH. Data sources for heart failure comparative effectiveness research. Heart Fail Clin. 2013;9(1):1–13.CrossRef
34.
go back to reference Dunlay SM, Alexander KP, Melloni C, Kraschnewski JL, Liang L, Gibler WB, et al. Medical records and quality care in acute coronary syndromes. JAMA. 2008;168(15):1692–8. Dunlay SM, Alexander KP, Melloni C, Kraschnewski JL, Liang L, Gibler WB, et al. Medical records and quality care in acute coronary syndromes. JAMA. 2008;168(15):1692–8.
35.
go back to reference Lyu H, Cooper M, Patel K, Daniel M, Makary MA. Prevalence and data transparency of National Clinical Registries in the United States. J Healthc Qual. 2016;38(4):223–34.CrossRef Lyu H, Cooper M, Patel K, Daniel M, Makary MA. Prevalence and data transparency of National Clinical Registries in the United States. J Healthc Qual. 2016;38(4):223–34.CrossRef
36.
go back to reference Austin C, Kusumoto F. The application of big data in medicine: current implications and future directions. J Interv Card Electrophysiol. 2016;47(1):51–9.CrossRef Austin C, Kusumoto F. The application of big data in medicine: current implications and future directions. J Interv Card Electrophysiol. 2016;47(1):51–9.CrossRef
Metadata
Title
Public reporting on cardiac electrophysiology procedures and outcomes: where are we now and where are we headed?
Authors
Samuel M. Kim
Jim W. Cheung
Publication date
01-11-2019
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology / Issue 2/2019
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-018-0400-9

Other articles of this Issue 2/2019

Journal of Interventional Cardiac Electrophysiology 2/2019 Go to the issue